Est. 120,000 EUR
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 120,000 EUR
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 40,000 EUR
Are you a Ukrainian language expert eager to shape the future of AI? Large-scale language models are evolving from clever chatbots into powerful engines of linguistic discovery. With high-quality training data, tomorrow’…
Est. 45,000 EUR
Are you a German language expert eager to shape the future of AI? Large‑scale language models are evolving from clever chatbots into powerful engines of linguistic discovery. With high‑quality training data, tomorrow’s A…
Est. 40,000 EUR
Are you a LaTeX expert fluent in Italian eager to shape the future of AI? Large‑scale language models are evolving from clever chatbots into powerful engines of scientific discovery. With high‑quality training data, tomo…
Est. 45,000 EUR
Are you an Italian language expert eager to shape the future of AI? Large‑scale language models are evolving from clever chatbots into powerful engines of linguistic discovery. With high‑quality training data, tomorrow’s…